Aurobindo Pharma's Pirfenidone Receives FDA Approval Status Update
Aurobindo Pharma's application for Pirfenidone (ANDA212597) has received an approval status update from the FDA.
Indication
Clinical and regulatory intelligence for Fibrosis with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.